Skip to main content

Main menu

  • Home
  • Content
    • Early Access
    • Current Issue
    • Kidney360 Podcasts
    • Subject Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Clinical Images
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
    • Editorial Team
    • Editorial Training Program
    • Reviewer Recognition
  • More
    • About Kidney360
    • Advertising
    • Disqus Commenting
    • Email Alerts
    • Feedback
    • Reprint Information
  • ASN Kidney News
  • Other
    • ASN Publications
    • JASN
    • CJASN
    • Kidney News Online
    • American Society of Nephrology

User menu

Search

  • Advanced search
American Society of Nephrology
  • Other
    • ASN Publications
    • JASN
    • CJASN
    • Kidney News Online
    • American Society of Nephrology
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Early Access
    • Current Issue
    • Kidney360 Podcasts
    • Subject Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Clinical Images
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
    • Editorial Team
    • Editorial Training Program
    • Reviewer Recognition
  • More
    • About Kidney360
    • Advertising
    • Disqus Commenting
    • Email Alerts
    • Feedback
    • Reprint Information
  • ASN Kidney News
  • Visit ASN on Facebook
  • Follow Kidney360 on Twitter
  • Community Forum
  • Kidney360 RSS
Original Investigation

Refractoriness of Hyperkalemia and Hyperphosphatemia in Dialysis-Dependent Acute Kidney Injury Associated with COVID-19

Swetha R. Kanduri, Akanksh Ramanand, Vipin Varghese, Yuang Wen, Muner M.B. Mohamed and Juan Carlos Q. Velez
Kidney360 May 2022, 10.34067/KID.0001632022; DOI: https://doi.org/10.34067/KID.0001632022
Swetha R. Kanduri
1Nephrology, Ochsner Health, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Swetha R. Kanduri
Akanksh Ramanand
2Ochsner Clinic Foundation, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vipin Varghese
2Ochsner Clinic Foundation, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuang Wen
3Nephrology, Ochsner Health System, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Muner M.B. Mohamed
3Nephrology, Ochsner Health System, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juan Carlos Q. Velez
4Ochsner Health, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Juan Carlos Q. Velez
  • For correspondence: juancarlos.velez@ochsner.org
  • Article
  • Info & Metrics
  • View PDF
Loading

Key Points

  • Refractory hyperK and hyperP are more frequent in CoV-AKI-RRT compared to pre-COVID-19 era.

  • Patients with CoV-AKI-RRT had elevated serum potassium and serum phosphate that corresponded with lactate dehydrogenase levels.

  • Intracellular ion release due to cytokine storm and RRT interruptions in CoV-AKI pts may account for elevated serum potassium and phosphate.

Abstract

Background: Persistent hyperkalemia (hyperK) and hyperphosphatemia (hyperP) despite renal replacement therapy (RRT) was anecdotally reported in COVID-19 and acute kidney injury (AKI) requiring RRT (CoV-AKI-RRT). However, observation bias could have accounted for the reports. Thus, we systematically examined the rate and severity of hyperK and hyperP in patients with CoV-AKI-RRT in comparison with pre-COVID-19 era. Methods: We identified patients with CoV-AKI-RRT treated with sustained low-efficiency dialysis (SLED) for ≥2 days in March-April 2020. As pre-COVID-19 control, we included patients with AKI treated with SLED who were part of a research database (2018-2019). We examined the rates of hyperK [serum potassium (sK) >=5.5 mEq/L], severe hyperK [sK >=6.5 mEq/L], hyperP [serum phosphate (sP) >=4.5 mg/dL] and moderate or severe hyperP [sP >=7.0-10.0 and >10.0 mg/dL, respectively] as %SLED-days with an event. Results: Along the duration of SLED, the incidence of hyperK was greater in CoV-AKI-RRT (n=64) [mean 19(2)% vs. 14(3)% SLED-days, p=0.002] compared to control (n=60). The proportion of patients with >=1 event of severe hyperK was greater in CoV-AKI [33% vs. 7%, p=0.0004]. The incidence of hyperP was similar between groups [mean 56(4)% vs. 53(5)% SLED-days, p=0.49]. However, the proportion of patients with >=1 event of moderate and severe hyperP was greater in CoV-AKI-RRT [86% vs. 60% (p=0.001) and 50% vs. 18% (p=0.0002), respectively]. Among those with CoV-AKI-RRT, sK and sP correlated with lactate dehydrogenase (LDH) [r=0.31 (p=0.044) and r=0.31 (p=0.043), respectively] whereas hyperP also correlated with shorter SLED runs (hours/run) (r=-0.27, p=0.055). Conclusion: Refractory hyperK and hyperP were more frequent in CoV-AKI-RRT compared to pre-COVID-19 era. Because of the correlation of sK and sP with higher LDH and sP with shorter SLED runs, intracellular ion release from cell injury due to cytokine storm and RRT interruptions may account for the findings.

  • potassium
  • coronavirus
  • SLED
  • electrolyte
  • phosphorus
  • COVID-19
  • CRRT
  • Hyperkalemia
  • Acute Kidney Injury
  • Hyperphosphatemia
  • Received March 1, 2022.
  • Revision received May 17, 2022.
  • Accepted May 17, 2022.
  • Copyright © 2022 American Society of Nephrology
PreviousNext
Back to top

In this issue

Kidney360: 3 (5)
Kidney360
Vol. 3, Issue 5
26 May 2022
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • About the Cover
  • Index by author
View Selected Citations (0)
Download PDF
Sign up for Alerts
Email Article

Thank you for your interest in spreading the word on American Society of Nephrology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Refractoriness of Hyperkalemia and Hyperphosphatemia in Dialysis-Dependent Acute Kidney Injury Associated with COVID-19
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
K+ and PO4- in AKI-RRT in COVID-19
Swetha R. Kanduri, Akanksh Ramanand, Vipin Varghese, Yuang Wen, Muner M.B. Mohamed, Juan Carlos Q. Velez
Kidney360 May 2022, 10.34067/KID.0001632022; DOI: 10.34067/KID.0001632022

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
K+ and PO4- in AKI-RRT in COVID-19
Swetha R. Kanduri, Akanksh Ramanand, Vipin Varghese, Yuang Wen, Muner M.B. Mohamed, Juan Carlos Q. Velez
Kidney360 May 2022, 10.34067/KID.0001632022; DOI: 10.34067/KID.0001632022
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
  • Info & Metrics
  • View PDF

More in this TOC Section

  • Osteopontin in CKD
  • Dysnatremia, Mortality, COVID-19
  • Medical Specialty Survey of Undergraduates.
Show more Original Investigation

Cited By...

  • No citing articles found.
  • Google Scholar

Similar Articles

Related Articles

  • No related articles found.
  • Google Scholar

Keywords

  • potassium
  • coronavirus
  • SLED
  • electrolyte
  • phosphorus
  • COVID-19
  • CRRT
  • Hyperkalemia
  • acute kidney injury
  • Hyperphosphatemia

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • Kidney360
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About Kidney360
  • Kidney360 Email Alerts
  • Kidney360 Podcasts
  • Kidney360 RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Subscribe to JASN and CJASN

© 2022 American Society of Nephrology

Online ISSN - 2641-7650

Powered by HighWire